Is It Time To Buy AbbVie?$AbbVie(ABBV)$ is one of the largest research-based biopharmaceutical companies in the world. The company has about 21,000 employees in more than 90 different countries. It owns 15 primary research and manufacturing facilities across the globe. At present, ABBV is working on 10 programs that are already in Phase III development. There are also more than 7 product candidates under Phase II study.AbbVie used to be a part of $Abbott Laboratories(ABT)$ . The parent company, Abbott, decided to split itself into two as a part of its business strategy. AABV entered the stock market at the beginning of this year. Since its market appearance, the stock gained about 16%. We think that there is sti

$Bed Bath & Beyond(BBBY)$ is a solid company that is on the brink of a spectacular resurgence due to its recent store modernization and e-commerce adaptation initiatives. As a result of these efforts, investors are becoming increasingly bullish on the company's future, and this is reflected in the steadily rising stock price.When it comes to the potential for a short squeeze, it is important to note that Bed Bath & Beyond's short float is one of the highest in stock market history. This means that there are a large number of investors who have taken short positions, i.e. they have sold shares they have not yet purchased. However, these investors are likely to be forced to cover their positions as the stock price continues to rise, leading to

$XIAOMI-W(01810)$  US federal judge Rudolph Contreras in Washington issued a preliminary injunction Friday preventing the US Department of Defense from restricting US investors from investing in Xiaomi Group.On Jan. 14, the US government placed nine Chinese companies, including Xiaomi, on a so-called Chinese military-related blacklist, preventing US investors from investing in the companies.The investment ban is set to take effect next week. Contreras, however, temporarily called off the ban on Friday.He argued that Xiaomi would likely reverse the ban altogether as the lawsuit unfolded, and issued a preliminary injunction to prevent Xiaomi from suffering "irreparable harm.In response to concerns raised by the US government about threats to

$DiDi Global Inc.(DIDIY)$  Some thoughts: I invest here because I believe in the Macro story behind this company. It's worldwide dominate position, and it's demographically driven bright future. Yes, I'm positioning myself for a 2X pop on App news (have been for awhile), but the real value is the slow steady rise to a reasonable market cap compared to it's peers. I predict conservatively valued at $9-10 bucks short to medium term. $16-18 longer (probably much more). Once the Apps return folks will perceive this company much differently as they'll look at it as being back in the "good graces" of China. And thus, free to rise (SP) again to a reasonable level.